Rebecca Liang
Stock Analyst at Bernstein
(4.44)
# 1,157
Out of 5,073 analysts
78
Total ratings
72.2%
Success rate
25.3%
Average return
Main Sectors:
Stocks Rated by Rebecca Liang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Reiterated: Hold | $130.00 → $104.00 | $92.05 | +12.98% | 19 | Oct 8, 2026 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $44.00 → $47.00 | $34.38 | +36.71% | 8 | Apr 22, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $545.00 → $526.00 | $472.00 | +11.44% | 3 | Mar 26, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $412 | $386.46 | +6.61% | 19 | Mar 18, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $115.00 | $90.80 | +26.65% | 14 | Mar 12, 2026 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Hold | $10.70 | $8.70 | +22.99% | 7 | Feb 9, 2026 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Reiterated: Hold | $7.90 | $5.36 | +47.53% | 4 | Feb 9, 2026 | |
| HKG: 9688 Zai Lab Limited | Reiterated: Hold | $18.00 | $19.03 | -5.41% | 4 | Feb 9, 2026 |
Akeso, Inc.
Oct 8, 2026
Reiterated: Hold
Price Target: $130.00 → $104.00
Current: $92.05
Upside: +12.98%
Hansoh Pharmaceutical Group Company Limited
Apr 22, 2026
Reiterated: Buy
Price Target: $44.00 → $47.00
Current: $34.38
Upside: +36.71%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Mar 26, 2026
Reiterated: Buy
Price Target: $545.00 → $526.00
Current: $472.00
Upside: +11.44%
BeOne Medicines AG
Mar 18, 2026
Reiterated: Buy
Price Target: $412
Current: $386.46
Upside: +6.61%
Innovent Biologics, Inc.
Mar 12, 2026
Reiterated: Buy
Price Target: $115.00
Current: $90.80
Upside: +26.65%
CSPC Pharmaceutical Group Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $10.70
Current: $8.70
Upside: +22.99%
Sino Biopharmaceutical Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $7.90
Current: $5.36
Upside: +47.53%
Zai Lab Limited
Feb 9, 2026
Reiterated: Hold
Price Target: $18.00
Current: $19.03
Upside: -5.41%